Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep-Oct;17(5):509-516.
doi: 10.21873/cgp.20207.

STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer

Shunsuke Nakamura  1 , Mitsuro Kanda  2 , Dai Shimizu  1 , Kouichi Sawaki  1 , Chie Tanaka  1 , Norifumi Hattori  1 , Masamichi Hayashi  1 , Suguru Yamada  1 , Goro Nakayama  1 , Kenji Omae  3 , Masahiko Koike, Yasuhiro Kodera  1
Affiliations

STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer

Shunsuke Nakamura et al. Cancer Genomics Proteomics. 2020 Sep-Oct.

Abstract

Background: Despite advances in our understanding on the pathogenesis of gastric cancer (GC), patients face a poor prognosis. To improve clinical outcomes, effective approaches to diagnosis and treatment employing new diagnostic biomarkers are required to achieve early detection and predict recurrence and prognosis.

Materials and methods: Transcriptome analysis was conducted using surgically resected gastric tissues from four patients with metastatic GC. A total of 228 pairs of primary GC tissues and corresponding normal adjacent tissues were subjected to mRNA expression analysis. To validate our findings, we accessed an integrated microarray dataset and RNA sequencing data of GC cell lines.

Results: We identified stimulated by retinoic acid 6 (STRA6) as a differentially overexpressed gene, which encodes a transmembrane protein that mediates the cellular uptake of retinol. To investigate how STRA6 contributes to the malignant phenotype of GC cells, we mined public datasets and found the mRNA encoding retinol binding protein 1 (RBP1), which is associated with retinoid metabolism, was co-expressed with STRA6. Furthermore, STRA6 mRNA levels were significantly higher in GC tissues compared to the corresponding noncancerous adjacent tissues of 228 surgically resected gastric tissue samples. Moreover, patients with high levels of STRA6 mRNA experienced significantly shorter disease-free survival and overall survival. Multivariate analysis revealed that high levels of STRA6 served as a significant risk factor.

Conclusion: Patients with high levels of STRA6 mRNA experienced significantly worse clinical outcomes, indicating that STRA6 may serve as a diagnostic and prognostic biomarker of GC.

Keywords: Gastric cancer; STRA6; biomarker; prognosis; recurrence.

PubMed Disclaimer

Conflict of interest statement

The Authors have no conflicts of interest with regard to the present study.

Figures

Figure 1
Figure 1. STRA6 mRNA expression in clinical samples and survival analysis. (A) Comparison of STRA6 mRNA levels in normal adjacent tissues and GC tissues according to UICC stage,. *p<0.05. (B) Kaplan–Meier analysis of disease-free survival (DFS) and overall survival (OS) in the institutional cohort. The analyses included 228 patients who underwent curative gastrectomy for stages I-III GC. (C) Kaplan–Meier analysis of OS in the external validation cohort. OS analysis included 444 patients who underwent curative gastrectomy for stages I-III GC.
Figure 2
Figure 2. Frequencies of initial recurrence after curative gastrectomy in patients according to STRA6 mRNA levels. *p<0.05.
See this image and copyright information in PMC

References

    1. Figueiredo C, Camargo MC, Leite M, Fuentes-Panana EM, Rabkin CS, Machado JC. Pathogenesis of gastric cancer: Genetics and molecular classification. Curr Top Microbiol Immunol. 2017;400:277–304. doi: 10.1007/978-3-319-50520-6_12. - DOI - PMC - PubMed
    1. Katona BW, Rustgi AK. Gastric cancer genomics: advances and future directions. Cell Mol Gastroenterol Hepatol. 2017;3(2):211–217. doi: 10.1016/j.jcmgh.2017.01.003. - DOI - PMC - PubMed
    1. Nakamura S, Kanda M, Kodera Y. Incorporating molecular biomarkers into clinical practice for gastric cancer. Expert Rev Anticancer Ther. 2019;19(9):757–771. doi: 10.1080/14737140.2019.1659136. - DOI - PubMed
    1. Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer. Int J Cancer. 2019;146:2865–2876. doi: 10.1002/ijc.32705. - DOI - PubMed
    1. Kanda M, Tanaka H, Shimizu D, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hattori N, Suenaga M, Hayashi M, Iwata N, Yamada S, Fujiwara M, Kodera Y. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells. Oncogene. 2018;37(39):5355–5366. doi: 10.1038/s41388-018-0335-8. - DOI - PubMed

MeSH terms